Inogen estimates preliminary, unaudited total revenue of about $82 million for the fourth quarter of ...

The Company estimates preliminary, unaudited total revenue in the fourth quarter of 2025 to be approximately $82 million, ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator ...

Inogen (INGN +5.2%) rose pre-market following its Q4 results on Feb. 24 post market. Q4 total revenue rose 3.3% Y/Y to $76.4M, missing analysts' estimates of $76.60M. The increase was mainly driven by ...

Inogen, in partnership with Yuwell, has taken another step toward becoming a comprehensive respiratory solutions company with ...

Please reference Inogen to join the call. A live audio webcast and archived recording of the conference call will be available to all interested parties through the News / Events page on the Inogen ...

Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet 1, pure 2, continuous flow oxygen ...

Inogen (INGN) shares soared 5.1% in the last trading session to close at $27.82. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2025 financial ...